1XN7

Solution Structure of E.Coli Protein yhgG: The Northeast Structural Genomics Consortium Target ET95

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	GFT (4,3)D HNNCabCa	1.13 mM, NMR Buffer 6.5, 5% D2O, 0.02% NaN3, 10mM DTT, 5mM CaCl2, 100mM NaCl, 20mM MES, pH 6.5	95% H2O/5% D2O		6.5	ambient	298
2	GFT (4,3)D CabCa(CO)NHN	1.13 mM, NMR Buffer 6.5, 5% D2O, 0.02% NaN3, 10mM DTT, 5mM CaCl2, 100mM NaCl, 20mM MES, pH 6.5	95% H2O/5% D2O		6.5	ambient	298
3	GFT (5,2)D HACACONHN	1.13 mM, NMR Buffer 6.5, 5% D2O, 0.02% NaN3, 10mM DTT, 5mM CaCl2, 100mM NaCl, 20mM MES, pH 6.5	95% H2O/5% D2O		6.5	ambient	298
4	Simultaneous Heteronuclear resolved [1H,1H]-NOESY	1.13 mM, NMR Buffer 6.5, 5% D2O, 0.02% NaN3, 10mM DTT, 5mM CaCl2, 100mM NaCl, 20mM MES, pH 6.5	95% H2O/5% D2O		6.5	ambient	298
5	GFT (4,3)D HCCH	1.13 mM, NMR Buffer 6.5, 5% D2O, 0.02% NaN3, 10mM DTT, 5mM CaCl2, 100mM NaCl, 20mM MES, pH 6.5	95% H2O/5% D2O		6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Varian	INOVA	750

NMR Refinement
Method	Details	Software
torsion angle dynamics		PROSA

NMR Ensemble Information
Conformer Selection Criteria	target function,structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Additional NMR Experimental Information
Details	This structure was determined using GFT techniques.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	PROSA	6.0	Guentert, P.
2	data analysis	XEASY	1.3.1.3	Bartels, C.
3	structure solution	DYANA	1.5	Guentert, P.
4	data analysis	AutoAssign	1.13.2	Zimmerman, D.E.
5	data analysis	AutoStructure	2.0.0	Huang, Y.J.
6	data analysis	CYANA	1.0.5	Guentert, P.
7	refinement	DYANA	1.5	Guentert, P.

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.